TABLE OF CONTENTS
1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.3 OVERVIEW 27
1.4 LIMITATIONS 29
1.5 MARKETS COVERED 29
2 MARKET SEGMENTATION 31
2.1 MARKETS COVERED 31
2.2 GEOGRAPHICAL SCOPE 32
2.3 YEARS CONSIDERED FOR THE STUDY 33
2.4 CURRENCY AND PRICING 33
2.5 DBMR TRIPOD DATA VALIDATION MODEL 34
2.6 MULTIVARIATE MODELLING 37
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 37
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 38
2.9 DBMR MARKET POSITION GRID 39
2.10 MARKET APPLICATION COVERAGE GRID 40
2.11 VENDOR SHARE ANALYSIS 41
2.12 SECONDARY SOURCES 42
2.13 ASSUMPTIONS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 PORTERS FIVE FORCES 49
4.2 VALUE CHAIN ANALYSIS: 50
4.3 COMPETITIVE ANALYSIS 51
4.4 BRAND ANALYSIS 53
4.5 ECOSYSTEM MAPS 54
4.6 TECHNOLOGICAL TRENDS 55
4.7 TOP WINNING STRATEGIES 56
5 MARKET OVERVIEW 57
5.1 DRIVERS 59
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 59
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 59
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 61
5.1.4 INCREASING GOVERNMENT INITIATIVES 61
5.2 RESTRAINTS 62
5.2.1 STRICT REGULATORY FRAMEWORK 62
5.2.2 LACK OF STANDARDIZATION 63
5.3 OPPORTUNITIES 63
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 63
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 64
5.4 CHALLENGES 65
5.4.1 LACK OF SKILLED PROFESSIONALS 65
5.4.2 RISK TO PATIENT'S DATA SECURITY 65
6 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 67
6.1 OVERVIEW 68
6.2 CARDIAC MONITORING DEVICES 71
6.3 BLOOD PRESSURE MONITORING DEVICES 72
6.4 MULTI-PARAMETER MONITORING DEVICES 73
6.5 BLOOD GLUCOSE MONITORING DEVICES 74
6.6 RESPIRATORY MONITORING DEVICES 75
6.7 NEUROLOGICAL MONITORING DEVICES 76
6.8 OTHERS 77
7 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 78
7.1 OVERVIEW 79
7.2 CARDIOVASCULAR DISEASE 82
7.2.1 CORONARY HEART DISEASE 83
7.2.2 STROKE 83
7.2.3 PERIPHERAL ARTERIAL DISEASE 83
7.2.4 AORTIC DISEASE 83
7.2.5 OTHERS 83
7.3 DIABETES 83
7.4 ONCOLOGY 84
7.5 OTHERS 85
8 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 86
8.1 OVERVIEW 87
8.2 HOME HEALTHCARE PATIENTS 90
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 91
8.2.2 CARDIAC MONITORING DEVICES 91
8.2.3 BLOOD PRESSURE MONITORING DEVICES 91
8.2.4 MULTI-PARAMETER MONITORING DEVICES 91
8.2.5 RESPIRATORY MONITORING DEVICES 91
8.2.6 NEUROLOGICAL MONITORING DEVICES 91
8.2.7 OTHERS 92
8.3 AMBULATORY PATIENTS 92
8.3.1 MULTI-PARAMETER MONITORING DEVICES 93
8.3.2 RESPIRATORY MONITORING DEVICES 93
8.3.3 CARDIAC MONITORING DEVICES 93
8.3.4 BLOOD PRESSURE MONITORING DEVICES 93
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 93
8.3.6 NEUROLOGICAL MONITORING DEVICES 93
8.3.7 OTHERS 94
8.4 HOSPITAL-BASED PATIENTS 94
8.4.1 MULTI-PARAMETER MONITORING DEVICES 95
8.4.2 CARDIAC MONITORING DEVICES 95
8.4.3 RESPIRATORY MONITORING DEVICES 95
8.4.4 BLOOD PRESSURE MONITORING DEVICES 95
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 95
8.4.6 NEUROLOGICAL MONITORING DEVICES 95
8.4.7 OTHERS 96
9 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 97
9.1 OVERVIEW 98
9.2 NORTH AMERICA 103
9.2.1 U.S. 111
9.2.2 CANADA 115
9.2.3 MEXICO 119
9.3 EUROPE 123
9.3.1 GERMANY 132
9.3.2 U.K. 136
9.3.3 FRANCE 140
9.3.4 ITALY 144
9.3.5 RUSSIA 148
9.3.6 SPAIN 152
9.3.7 TURKEY 156
9.3.8 SWITZERLAND 160
9.3.9 NETHERLANDS 164
9.3.10 BELGIUM 168
9.3.11 REST OF EUROPE 172
9.4 ASIA-PACIFIC 173
9.4.1 CHINA 182
9.4.2 JAPAN 186
9.4.3 AUSTRALIA 190
9.4.4 INDIA 194
9.4.5 SOUTH KOREA 198
9.4.6 SINGAPORE 202
9.4.7 MALAYSIA 206
9.4.8 THAILAND 210
9.4.9 INDONESIA 214
9.4.10 PHILIPPINES 218
9.4.11 REST OF ASIA-PACIFIC 222
9.5 SOUTH AMERICA 223
9.5.1 BRAZIL 231
9.5.2 ARGENTINA 235
9.5.3 REST OF SOUTH AMERICA 238
9.6 MIDDLE EAST AND AFRICA 239
9.6.1 SOUTH AFRICA 247
9.6.2 EGYPT 251
9.6.3 ISRAEL 255
9.6.4 UAE 259
9.6.5 SAUDI ARABIA 263
9.6.6 REST OF MIDDLE EAST AND AFRICA 267
10 GLOBAL REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 268
10.1 COMPANY SHARE ANALYSIS: GLOBAL 268
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 269
10.3 COMPANY SHARE ANALYSIS: EUROPE 270
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 271
11 SWOT ANALYSIS 272
12 COMPANY PROFILE 273
12.1 MEDTRONIC 273
12.1.1 COMPANY SNAPSHOT 273
12.1.2 REVENUE ANALYSIS 274
12.1.3 COMPANY SHARE ANALYSIS 274
12.1.4 PRODUCT PORTFOLIO 275
12.1.5 RECENT DEVELOPMENT 275
12.2 DEXCOM, INC. 276
12.2.1 COMPANY SNAPSHOT 276
12.2.2 REVENUE ANALYSIS 276
12.2.3 COMPANY SHARE ANALYSIS 277
12.2.4 PRODUCT PORTFOLIO 277
12.2.5 RECENT DEVELOPMENT 277
12.3 ABBOTT 278
12.3.1 COMPANY SNAPSHOT 278
12.3.2 REVENUE ANALYSIS 278
12.3.3 COMPANY SHARE ANALYSIS 279
12.3.4 PRODUCT PORTFOLIO 279
12.3.5 RECENT DEVELOPMENT 279
12.4 RESMED 280
12.4.1 COMPANY SNAPSHOT 280
12.4.2 REVENUE ANALYSIS 280
12.4.3 COMPANY SHARE ANALYSIS 281
12.4.4 PRODUCT PORTFOLIO 281
12.4.5 RECENT DEVELOPMENT 281
12.5 BIOTRONIK SE & CO. KG 282
12.5.1 COMPANY SNAPSHOT 282
12.5.2 COMPANY SHARE ANALYSIS 282
12.5.3 PRODUCT PORTFOLIO 283
12.5.4 RECENT DEVELOPMENT 283
12.6 100 PLUS. 284
12.6.1 COMPANY SNAPSHOT 284
12.6.2 PRODUCT PORTFOLIO 284
12.6.3 RECENT DEVELOPMENTS 284
12.7 A&D COMPANY, LIMITED 285
12.7.1 COMPANY SNAPSHOT 285
12.7.2 REVENUE ANALYSIS 285
12.7.3 COMPANY SHARE ANALYSIS 286
12.7.4 PRODUCT PORTFOLIO 286
12.7.5 RECENT DEVELOPMENT 286
12.8 AEROTEL MEDICAL SYSTEMS 287
12.8.1 COMPANY SNAPSHOT 287
12.8.2 PRODUCT PORTFOLIO 287
12.8.3 RECENT DEVELOPMENT 287
12.9 ALIVECOR, INC. 288
12.9.1 COMPANY SNAPSHOT 288
12.9.2 COMPANY SHARE ANALYSIS 288
12.9.3 PRODUCT PORTFOLIO 288
12.9.4 RECENT DEVELOPMENTS 289
12.10 BIOBEAT 290
12.10.1 COMPANY SNAPSHOT 290
12.10.2 PRODUCT PORTFOLIO 290
12.10.3 RECENT DEVELOPMENT 290
12.11 BOSTON SCIENTIFIC CORPORATION 291
12.11.1 COMPANY SNAPSHOT 291
12.11.2 REVENUE ANALYSIS 292
12.11.3 COMPANY SHARE ANALYSIS 292
12.11.4 PRODUCT PORTFOLIO 292
12.11.5 RECENT DEVELOPMENT 293
12.12 CARDIOMO 294
12.12.1 COMPANY SNAPSHOT 294
12.12.2 PRODUCT PORTFOLIO 294
12.12.3 RECENT DEVELOPMENTS 294
12.13 CHRONISENSE MEDICAL, LTD. 295
12.13.1 COMPANY SNAPSHOT 295
12.13.2 PRODUCT PORTFOLIO 295
12.13.3 RECENT DEVELOPMENT 295
12.14 COACHCARE 296
12.14.1 COMPANY SNAPSHOT 296
12.14.2 PRODUCT PORTFOLIO 296
12.14.3 RECENT DEVELOPMENT 296
12.15 GENERAL ELECTRIC 297
12.15.1 COMPANY SNAPSHOT 297
12.15.2 REVENUE ANALYSIS 297
12.15.3 COMPANY SHARE ANALYSIS 298
12.15.4 PRODUCT PORTFOLIO 298
12.15.5 RECENT DEVELOPMENT 298
12.16 KONINKLIJKE PHILIPS N.V. 299
12.16.1 COMPANY SNAPSHOT 299
12.16.2 REVENUE ANALYSIS 299
12.16.3 COMPANY SHARE ANALYSIS 300
12.16.4 PRODUCT PORTFOLIO 300
12.16.5 RECENT DEVELOPMENT 300
12.17 MASIMO 301
12.17.1 COMPANY SNAPSHOT 301
12.17.2 REVENUE ANALYSIS 301
12.17.3 COMPANY SHARE ANALYSIS 302
12.17.4 PRODUCT PORTFOLIO 302
12.17.5 RECENT DEVELOPMENT 302
12.18 NETEERA 303
12.18.1 COMPANY SNAPSHOT 303
12.18.2 PRODUCT PORTFOLIO 303
12.18.3 RECENT DEVELOPMENT 303
12.19 NIHON KOHDEN CORPORATION 304
12.19.1 COMPANY SNAPSHOT 304
12.19.2 REVENUE ANALYSIS 304
12.19.3 COMPANY SHARE ANALYSIS 305
12.19.4 PRODUCT PORTFOLIO 305
12.19.5 RECENT DEVELOPMENT 305
12.20 OMRON CORPORATION 306
12.20.1 COMPANY SNAPSHOT 306
12.20.2 REVENUE ANALYSIS 306
12.20.3 COMPANY SHARE ANALYSIS 307
12.20.4 PRODUCT PORTFOLIO 307
12.20.5 RECENT DEVELOPMENT 307

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.